Unraveling the genetic landscape of ALS in Greece: identification of known and novel causative variants in a 353-patient cohort

Chrisoula Kartanou(National and Kapodistrian University of Athens), Zoi Kontogeorgiou(National and Kapodistrian University of Athens), Theodoros Loupis(Academy of Athens), Dimitrios Miltiadis Vrachnos(Academy of Athens), Nikolaos Ragazos(National and Kapodistrian University of Athens), Ifigenia Spyropoulou(National and Kapodistrian University of Athens), Maria Petraki(National and Kapodistrian University of Athens), Chrysoula Koniari(National and Kapodistrian University of Athens), Stavroula Aristeidou(National and Kapodistrian University of Athens), Eleftheria Koropouli(National and Kapodistrian University of Athens), Ariadne Daponte(National and Kapodistrian University of Athens), Michail Rentzos(National and Kapodistrian University of Athens), E. Kapaki(National and Kapodistrian University of Athens), Μάριος Πάνας(National and Kapodistrian University of Athens), Periklis Makrythanasis(University of Geneva), Leonidas Stefanis(National and Kapodistrian University of Athens), Georgios Koutsis(National and Kapodistrian University of Athens), Georgia Karadima(National and Kapodistrian University of Athens)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
November 6, 2025
Cited by 0

Abstract

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is an adult-onset, progressive, fatal neurodegenerative disorder characterized by progressive loss of motor neurons. Approximately 15% of individuals diagnosed with ALS have a known genetic variant that contributes to disease. Herein, we present clinical and genetic data of a large Greek ALS cohort. PATIENTS AND METHODS: were investigated using ExpansionHunter software, repeat-primed PCR and fragment analysis. RESULTS: . CONCLUSION: Our results reveal the distinct genetic profile of Greek ALS patients. These findings will have an impact on genetic counseling, the design of diagnostic gene panels for the Greek population and on genotype-specific therapeutic interventions. Understanding the genetic causes of ALS in different populations is becoming increasingly important, especially with the advent of personalized medicine.


Related Papers

No related papers found

Powered by citation graph analysis